Accelerated approval: FDA explains when it considers confirmatory trials underway
Regulatory NewsFerdous Al-FaruqueApproval/marketing authorizationClinical TrialsComplianceGuidancePharmaceuticalsProduct developmentRegulatory Intelligence/PolicyUnited States